Immune responses to an encapsulated allogeneic islet beta-cell line in diabetic NOD mice.

Our goal is to develop effective islet grafts for treating type 1 diabetes. Since human islets are scarce, we evaluated the efficacy of a microencapsulated insulin-secreting conditionally transformed allogeneic beta-cell line (betaTC-tet) in non-obese diabetic mice treated with tetracycline to inhibit cell growth. Relatively low serum levels of tetracycline controlled proliferation of betaTC-tet cells without inhibiting effective control of hyperglycemia in recipients. There was no significant host cellular reaction to the allografts or host cell adherence to microcapsules, and host cytokine levels were similar to those of sham-operated controls. We conclude that encapsulated allogeneic beta-cell lines may be clinically relevant, because they effectively restore euglycemia and do not elicit a strong cellular immune response following transplantation. To our knowledge, this is the first extensive characterization of the kinetics of host cellular and cytokine responses to an encapsulated islet cell line in an animal model of type 1 diabetes.

[1]  G. Christofori,et al.  Correction of Hyperglycemia in Diabetic Mice Transplanted with Reversibly Immortalized Pancreatic β Cells Controlled by the tet-on Regulatory System , 2001, Cell transplantation.

[2]  N. Kobayashi,et al.  A human β-cell line for transplantation therapy to control type 1 diabetes , 2005, Nature Biotechnology.

[3]  S. Efrat,et al.  Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Kapp,et al.  Proliferative and Cytokine Responses in CTLA4-Ig-Treated Diabetic NOD Mice Transplanted with Microencapsulated Neonatal Porcine ICCs , 2002, Cell transplantation.

[5]  E. Benner,et al.  Simplified, accurate method for antibiotic assay of clinical specimens. , 1966, Applied microbiology.

[6]  J. Miyazaki,et al.  Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets , 1993, Diabetologia.

[7]  N. Simpson,et al.  Effects of growth regulation on conditionally-transformed alginate-entrapped insulin secreting cell lines in vitro. , 2005, Biomaterials.

[8]  S. Efrat,et al.  Clonal Insulinoma Cell Line That Stably Maintains Correct Glucose Responsiveness , 1994, Diabetes.

[9]  A. Cooke,et al.  Complement Lytic Activity Has No Role in the Pathogenesis of Autoimmune Diabetes in NOD Mice , 1993, Diabetes.

[10]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[11]  T. Strom,et al.  Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats. , 1984, Journal of immunology.

[12]  I. Weissman,et al.  Flow cytometric identification of murine neutrophils and monocytes. , 1996, Journal of immunological methods.

[13]  Jerrold M. Olefsky,et al.  Diabetes mellitus : a fundamental and clinical text , 2004 .

[14]  S. Efrat.  Cell replacement therapy for type 1 diabetes. , 2002, Trends in molecular medicine.

[15]  H. Kolb,et al.  MHC Class II–Dependent Abnormal Reactivity Toward Bacterial Superantigens in Immune Cells of NOD Mice , 1997, Diabetes.

[16]  C. Ricordi,et al.  Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. , 1998, Diabetes.

[17]  L. Rossetti,et al.  Functional analysis of a conditionally transformed pancreatic beta-cell line. , 1998, Diabetes.

[18]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[19]  J. Gaedeke,et al.  Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Greiner,et al.  Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. , 1995, Journal of immunology.

[21]  H. Ijima,et al.  MIN6 cells-enclosing aminopropyl-silicate membrane templated by alginate gels differences in guluronic acid content. , 2004, International journal of pharmaceutics.

[22]  J. Kapp,et al.  Evaluation of Graft‐Host Response for Various Tissue Sources and Animal Models , 1999, Annals of the New York Academy of Sciences.

[23]  A. Shapiro,et al.  Five-year follow-up after clinical islet transplantation. , 2005, Diabetes.

[24]  G. Warnock,et al.  Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. , 1990, The Journal of clinical endocrinology and metabolism.

[25]  J. Fishman,et al.  Xenotransplantation: Infectious Risk Revisited , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  B. Hering,et al.  Inhibition of Cellular Immune Responses to Encapsulated Porcine Islet Xenografts by Simultaneous Blockade of Two Different Costimulatory Pathways , 2005, Transplantation.

[27]  Mark S. Anderson,et al.  The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.